For those of you interested in the topic of statistics in mass and class actions, U. Conn. Law Professor and Mass Tort Litigation Blog contributor Alexandra D. Lahav has written an academic paper on the subject in the Texas Law Review, aptly entitled The Case for “Trial by Formula.” For Professor Lahav’s synopsis of the paper, a link to [...]
Posts Tagged ‘mass tort’
Another Viewpoint on “Trial by Formula”
Posted in Class Action Trends, tagged class action, drogin, dukes, lahav, mass action, mass tort, sampling, statistical method, statistics, trial by formula, wal-mart on April 9, 2012 | Leave a Comment »
Drug and Device Product Liability Litigation Strategy – An Indispensible Practice Guide
Posted in Mass Tort, Practice Tips, tagged drug and device, mass tort, mdl, medical products liability, multidistrict litigation, practice guide, practice tip, product liability, products liability on January 24, 2012 | Leave a Comment »
In December, I posted this preview of the then forthcoming book, Drug and Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden (Oxford University Press 2011). I received my copy of the book just before the holidays, and it is as good as advertised. The book has many strengths. It is comprehensive, generally accessible, eloquently written, [...]
Notes from the 5th Annual Conference on the Globalization of Class Actions and Mass Litigation, Session 6 – Paths to (Mass) Justice
Posted in Class Action Trends, CLE Programs, International Class Action Law, tagged Class Action Trends, collective action, collective redress, european class action, european collective action, international class action, mass harm, mass injury, mass tort, prediction on January 13, 2012 | 1 Comment »
This is the sixth and final installment of a multi-part post summarizing last week’s 5th Annual Conference on the Globalization of Class Actions and Mass Litigation. Click these links to see the summaries for Session 1, Session 2, Session 3, Session 4, and Session 5. Paths to (Mass) Justice To wrap up the conference, Dr. Sam [...]
Notes from the 5th Annual Conference on the Globalization of Class Actions and Mass Litigation, Session 4 – Giving Away Money
Posted in Class Action Settlements, CLE Programs, International Class Action Law, tagged 9/11, agent orange, altena, bp, compensation program, des, feinberg, gulf coast, indian residential schools, iran, iraq, irs, kalajdzic, kuwait, mass claims, mass tort, mcgovern, reparation, rough justice, september 11, settlement fund, united nations, wuhler on December 30, 2011 | 3 Comments »
This is the fourth in a multi-part post summarizing last week’s 5th Annual Conference on the Globalization of Class Actions and Mass Litigation. Click these links to see the summaries for Session 1, Session 2, and Session 3. Giving Away Money: Calculating Damages & Allocating Damages Professor Francis McGovern, Duke University Law School chaired this [...]
Looking for a Primer on Drug and Device Products Liability Litigation? Look No Further.
Posted in Lawyers' Resources, tagged alden, drug and device law, herrmann, mass tort, pharmaceutical, product liability, product liability class action, products liability, products liability class action on December 1, 2011 | 1 Comment »
Ok, just a bit further… Mark Herrmann, former contributor to the wildly successful Drug and Device Law Blog, sent me a note the other day that his book co-authored with Jones Day Partner David B. Alden entitled Drug and Device Product Liability Litigation Strategy (Oxford Univ. Press 2011) is now available. Here is a link to [...]
Judge Jack Weinstein on Judge Jack Weinstein
Posted in Articles, class action reform, Class Action Trends, tagged agent orange, asbestos, breast implant class action, cardozo law review, hand gun class action, jack weinstein, mass tort, tobacco, zyprexa on June 8, 2009 | Leave a Comment »
Senior U.S. District Court Judge Jack B. Weinstein (E.D.N.Y), has become well known for his often-cited and sometimes controversial opinions in mass tort and class action cases. He recently authored a commentary in the Cardozo Law Review’s new online journal de novo on some of his key decisions in cases involving subjects ranging from Agent Orange, asbestos, and tobacco to breast [...]

